FREQUENCY OF COMMON COMPLICATIONS OF POST PLACENTAL INTRAUTERINE CONTRACEPTIVE DEVICE IN PREGNANT WOMEN POPULATION OF D.I.KHAN DIVISION OF PAKISTAN
Keywords:
KEYWORDS: complications, post-placental, intrauterine device, pregnant women. Department of Gynecology and Obstetrics, Gomal Medical, D.I. KhanAbstract
ABSTRACT
INTRODUCTION: Pakistan is the sixth most populous country with an estimated population of1 80 million in 2012. In 1953 and 1960, Pakistan launched private and public contraceptivep rograms (FPs), respectively. The prevalence of contraception (CPR) increased by only 0.25%e ach year until 1990. The results of this study are specifically published in the literature tou nderstand the seriousness of the problem and to provide field supervisors to make the necessarya nd timely decisions on the use of IUCDs after placenta. OBJECTIVE: To determine thef requency of common complications of postplacental intrauterine devices in pregnant women int he Pakistani division D.I.KHAN. MATERIALS AND METHODS: Descriptive research byG omal Medical, D.I. Conducted in gynecology and obstetrics. In this study, a total of 254p atients were followed during the 6 months from March 4, 2017 to September 4, 2017. Allp atients woke up with a detailed medical history and laboratory tests, and routine tests werer removed from all patients. A post-placental IUCD was placed. All patients were carefullye valuated after 1 month for common postplacental IUCD complications such as dropout,b leeding, and pain. All observations were performed under the supervision of an experiencedC PSP obstetrician and gynecologist, and all laboratory tests were performed by an experiencedp athologist with at least 5 years of experience. RESULTS: During this study, the average agew as 27 + 11.26 SD years. Forty-two percent of patients were first-born and 58% of patients werem ultiparous. In addition, 10% of patients were expelled, 15% were bleeding, and 12% were inp ain. CONCLUSIONS: Our study found that bleeding (15%), followed by pain (12%) andd ropout (10%) were the most common complications in pregnant women treated withp ostplacental intrauterine prophylaxis. I concluded.